Seelos Therapeutics
Seelos Therapeutics: signs a material agreement, sells unregistered shares and discloses other events
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001136261-21-000250
- Document
- 8-K
- Exhibit 10.1
- Exclusive license agreement
- Exhibit 10.2
- Common stock purchase agreement
- Exhibit 99.1
- Press release
- Signs a material agreement (1.01)
- Sells unregistered shares (3.02)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
